Loading…
Harte Hanks, Inc. is projected to rise to $2.32 by 2027, a +16% move from its current price of $2.00. HHS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.94 | $2.00 | $2.06 | +0.01% |
| Aug 6 | $1.92 | $2.00 | $2.08 | +0.02% |
| Aug 7 | $1.90 | $2.00 | $2.10 | +0.02% |
| Aug 8 | $1.89 | $2.00 | $2.12 | +0.03% |
| Aug 9 | $1.87 | $2.00 | $2.14 | +0.04% |
| Aug 10 | $1.86 | $2.00 | $2.15 | +0.05% |
| Aug 11 | $1.85 | $2.00 | $2.16 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.85 | $2.00 | $2.16 | +0.06% |
| Week 2 | $1.79 | $2.00 | $2.23 | +0.11% |
| Week 3 | $1.75 | $2.00 | $2.29 | +0.17% |
| Week 4 | $1.72 | $2.00 | $2.34 | +0.23% |
| Week 5 | $1.69 | $2.01 | $2.39 | +0.28% |
| Week 6 | $1.66 | $2.01 | $2.43 | +0.34% |
| Week 7 | $1.64 | $2.01 | $2.47 | +0.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics.
It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research and intelligence, helps in understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services. It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand and distributing literature, managing product recalls, and promotional and branded product distribution; and third-party logistics and freight optimization services. In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology.
It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.
Harte Hanks, Inc. trades under the symbol HHS and has a market cap of $16.32M, ranked 4718. The current price is $2.20 per share. This setup places the stock in a smaller market segment with notable volatility and liquidity considerations.
A major floor 8.5% below — a decisive break under it would weaken the trend.
Support has flipped 3.5% overhead — reclaiming it would be bullish.
The nearest ceiling, 24.5% above — a clean break opens room to run.
A major ceiling 45.0% above — clearing it would confirm fresh momentum.
Key HHS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HHS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.26 | Sell | $2.25 | Sell |
| MA 10 | $2.32 | Sell | $2.30 | Sell |
| MA 20 | $2.35 | Sell | $2.33 | Sell |
| MA 50 | $2.42 | Sell | $2.42 | Sell |
| MA 100 | $2.54 | Sell | $2.56 | Sell |
| MA 200 | $2.81 | Sell | $2.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.64 | Neutral |
| Stoch RSI (14) | 6.95 | Buy |
| CCI (20) | -131.69 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -9.88 | Sell |
| Bollinger %B (20,2) | 0.06 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | -0.09 | Sell |
| Ultimate (7,14,28) | 36.38 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.18 | Sell |
| ADX (14) | 12.77 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is neutral with RSI(14) at 50. The stock trades around moving averages, with SMA50 at $2.47 and SMA200 at $2.85. Near-term support is at $2.07 and resistance at $2.53. The 30-day range spans from $1.85 to $2.61, highlighting a relatively tight trading window around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.00 | $2.00 | $2.69 | 0% | Neutral | |
| $1.83 | $2.32 | $3.10 | +16% | Neutral | |
| $1.76 | $2.29 | $3.18 | +14% | Neutral | |
| $1.82 | $2.43 | $3.49 | +21% | Bullish | |
| $1.68 | $2.29 | $3.37 | +14% | Neutral | |
| $1.74 | $2.43 | $3.66 | +21% | Bullish | |
| $1.99 | $2.83 | $4.35 | +41% | Bullish | |
| $2.08 | $3.00 | $4.71 | +50% | Bullish | |
| $2.38 | $3.50 | $5.58 | +75% | Bullish | |
| $2.51 | $3.75 | $6.07 | +88% | Bullish | |
| $3.06 | $4.92 | $8.49 | +146% | Bullish | |
| $4.66 | $8.52 | $16.17 | +326% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.00 | $2.00 | $2.48 | +0.00% |
| September 2026 | $1.74 | $2.06 | $2.51 | +2.84% |
| October 2026 | $1.69 | $2.01 | $2.49 | -2.04% |
| November 2026 | $1.73 | $2.07 | $2.58 | +2.93% |
| December 2026 | $1.78 | $2.15 | $2.69 | +3.48% |
Click any year to see its month-by-month HHS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect HHS to range from $2.00 to $2.69 through 2026. The $2.00 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The HHS price prediction for 2027 points to an average of $2.32 (low $1.83, high $3.10) — a potential gain of +16% on today's $2.00. A consolidation phase looks the most probable path here.
In 2028, HHS is projected to trade between $1.76 and $3.18, averaging $2.29 — a potential gain of +14% from today's $2.00. That is -1% versus the projected 2027 average. Price action looks broadly range-bound.
Harte Hanks, Inc.'s 2029 outlook centres on $2.43, within a $1.82 to $3.49 range. That is up +6% on the projected 2028 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, HHS could reach as high as $3.37, with a base case around $2.29 and support toward $1.68 — roughly +14% from $2.00. Price action looks broadly range-bound.
Expect HHS to range from $1.74 to $3.66 through 2031. The $2.43 average target implies a +21% move from current prices. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The HHS price prediction for 2032 points to an average of $2.83 (low $1.99, high $4.35) — a potential gain of +41% on today's $2.00. Momentum favours further upside here.
In 2033, HHS is projected to trade between $2.08 and $4.71, averaging $3.00 — a potential gain of +50% from today's $2.00. That is up +6% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Harte Hanks, Inc.'s 2034 outlook centres on $3.50, within a $2.38 to $5.58 range. That is up +17% on the projected 2033 average. That marks a +75% change versus current levels. Momentum favours further upside here.
By 2035, HHS could reach as high as $6.07, with a base case around $3.75 and support toward $2.51 — roughly +88% from $2.00. Buyers look set to stay in control over this stretch.
Expect HHS to range from $3.06 to $8.49 through 2040. The $4.92 average target implies a +146% move from current prices. That is up +31% on the projected 2035 average. Momentum favours further upside here.
The HHS price prediction for 2050 points to an average of $8.52 (low $4.66, high $16.17) — a potential gain of +326% on today's $2.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in HHS today (≈ 500 HHS) could be worth
$4,259.1
+$3,259.1 (+326%) by 2050 · US Dollar
Based on the average projected HHS price of $8.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HHSwould be worth at today's price.
$1,000 invested in HHS on Jul 31, 2025 (≈ 293.255125 HHS) would be worth
$586.51
-$413.49 (-41.3%) today · 0.59× · US Dollar
Based on a HHS entry price of $3.41 vs. today's $2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.39 | $836.82 | -16.3% |
| 1 month ago | $2.27 | $881.06 | -11.9% |
| 3 months ago | $2.74 | $729.93 | -27.0% |
| 6 months ago | $3.02 | $662.25 | -33.8% |
| 1 year ago | $3.41 | $586.51 | -41.3% |
| All time (5.0y) ago | $6.28 | $318.47 | -68.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HHS forecast.
Our base-case forecast reaches $4.00 around 2040.
Implied market cap at $4.00: $29.68M
Multi-year forecasts project a rising average price and expanding upside. For 2026 the min is $2.07, the avg is $2.20, the max is $2.93 with 0% ROI and neutral sentiment. By 2027 the avg rises to $2.53 (ROI 15.1%), and in 2028 the avg is $2.54 (ROI 15.3%), remaining neutral.
In 2029 the avg reaches $2.68 with a 21.9% ROI and a bullish outlook. The 2030 forecast shows an avg of $2.58 (ROI 17.1%), followed by 2031 at $2.76 (ROI 25.6%) and 2032 at $3.18 (ROI 44.3%), both bullish. By 2033 the avg is $3.38 (ROI 53.7%), 2034 $3.93 (ROI 78.6%), and 2035 $4.18 (ROI 89.8%), all bullish.
The longer horizon projects continued upside with 2040 at $5.58 (ROI 153.7%) and 2050 at $9.61 (ROI 336.9%), with bullish sentiment accompanying the ascent. These are estimates and not guarantees, but they illustrate a long-run path toward higher averages and meaningful ROIs, punctuated by more pronounced gains later in the horizon.
Tap a question to reveal the answer.
2030 avg $2.58, min $1.92, max $3.71, ROI 17.1%, sentiment NEUTRAL.
The forecast shows a path from 0% ROI in 2026 to progressively higher ROIs, reaching 15.1% in 2027, 15.3% in 2028, 21.9% in 2029, and up to 336.9% by 2050, with sentiment turning bullish in later years.
Yes. The forecast projects an average price of $5.58 by 2040 and $9.61 by 2050, with a maximum of $17.50 in 2050.
The 2026 forecast shows min $2.07, avg $2.20, max $2.93 with 0% ROI and sentiment NEUTRAL.
The highest forecast price by 2050 is a max of $17.50, with an average of $9.61 and ROI of 336.9%, sentiment BULLISH.
Harte Hanks, Inc. Community Discussion
0Share your Harte Hanks, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.